Literature DB >> 12354443

Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy.

Akiyasu Baba1, Tsutomu Yoshikawa, Satoshi Ogawa.   

Abstract

OBJECTIVES: We sought to test the hypothesis that autoantibodies (Abs) produced against sarcolemmal Na-K-ATPase play a role in the development of ventricular tachycardia (VT) and cardiac sudden death in patients with dilated cardiomyopathy (DCM).
BACKGROUND: Autoimmunity is one of the mechanisms of pathogenesis of DCM as well as virus infection and genetic predisposition.
METHODS: One hundred patients with DCM and age-matched control subjects (CTL) were screened for Abs produced against Na-K-ATPase by using enzyme-linked immunosorbent assay.
RESULTS: Abs were detected in 26 DCM and 2 CTL patients. Na-K-ATPase activity in the presence of patient IgG was lower in DCM with Abs than without Abs, but there was no difference between two groups in CTL. Western blots showed that Abs recognized the alpha subunit of Na-K-ATPase, and 3H-ouabain bindings in the presence of patient IgG showed that dissociation constant was higher in DCM with Abs than without Abs. No difference existed between subjects with regard to age, gender, New York Heart Association functional class, cardiac function, or neurohormone levels, except for plasma norepinephrine, which was higher in patients with Abs than without Abs. VTs were more common in patients with Abs than without Abs, and multiple logistic regression analysis demonstrated that the presence of Abs, but not plasma norepinephrine, was an independent predictor for the occurrence of VT. Cardiac sudden death was independently predicted by the presence of Abs, as well as poor systolic function.
CONCLUSION: We conclude that there are Abs produced against sarcolemmal Na-K-ATPase in patients with DCM and that Abs could be responsible for the electrical instability in some cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354443     DOI: 10.1016/s0735-1097(02)02075-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 2.  Autoantibodies and cardiac arrhythmias.

Authors:  Hon-Chi Lee; Kristin T L Huang; Xiao-Li Wang; Win-Kuang Shen
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

3.  Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; Anne Cotleur; Wai Hong Wilson Tang
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

Review 4.  The Role of B Cells in Cardiomyopathy and Heart Failure.

Authors:  Kevin Bermea; Aashik Bhalodia; Angelo Huff; Sylvie Rousseau; Luigi Adamo
Journal:  Curr Cardiol Rep       Date:  2022-06-11       Impact factor: 3.955

Review 5.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

Review 6.  [Immunoadsorption for treatment of dilated cardiomyopathy].

Authors:  S B Felix; M Dörr; L R Herda; D Beug; A Staudt
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 7.  The role of B-cells in heart failure.

Authors:  Andrea M Cordero-Reyes; Keith A Youker; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

8.  Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure.

Authors:  Haiyun Yu; Juanhui Pei; Xiaoyan Liu; Jingzhou Chen; Xian Li; Yinhui Zhang; Ning Li; Zengwu Wang; Ping Zhang; Kejiang Cao; Jielin Pu
Journal:  Dis Markers       Date:  2014-03-10       Impact factor: 3.434

Review 9.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.

Authors:  Alida L P Caforio; Renzo Marcolongo; Roland Jahns; Michael Fu; Stephan B Felix; S Iliceto
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.654

10.  Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.

Authors:  Tsutomu Yoshikawa; Akiyasu Baba; Makoto Akaishi; Yasuhisa Wakabayashi; Toshiaki Monkawa; Masafumi Kitakaze; Tohru Izumi; Hitonobu Tomoike
Journal:  J Clin Apher       Date:  2016-01-23       Impact factor: 2.821

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.